Johnson Johnson Visn Drug Patent Portfolio
Johnson Johnson Visn owns 1 orange book drug protected by 2 US patents Given below is the list of Johnson Johnson Visn's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9962376 | Methods and ophthalmic devices used in the treatment of ocular allergies | 27 Jun, 2030 | Active |
| US9474746 | Methods for stabilizing oxidatively unstable compositions | 27 Mar, 2028 | Active |
Latest Legal Activities on Johnson Johnson Visn's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Johnson Johnson Visn.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Apr, 2024 | US9474746 |
|
Email Notification
Critical
| 06 Mar, 2024 | US9962376 |
| Patent eCofC Notification | 05 Mar, 2024 | US9962376 |
|
Email Notification
Critical
| 05 Mar, 2024 | US9962376 |
| Recordation of Patent eCertificate of Correction | 05 Mar, 2024 | US9962376 |
| Mail Patent eCofC Notification | 05 Mar, 2024 | US9962376 |
| Post Issue Communication - Certificate of Correction | 14 Feb, 2024 | US9962376 |
|
Email Notification
Critical
| 01 Feb, 2024 | US9962376 |
| Mail Pet Dec Routed to Certificate of Corrections Branch | 31 Jan, 2024 | US9962376 |
| Mail-Petition Decision - Granted | 30 Jan, 2024 | US9962376 |
| Pet Dec Routed to Certificate of Corrections Branch | 29 Jan, 2024 | US9962376 |
|
Petition Decision - Granted
Critical
| 29 Jan, 2024 | US9962376 |
| Petition Entered | 30 Nov, 2023 | US9962376 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Oct, 2021 | US9962376 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Apr, 2020 | US9474746 |
Johnson Johnson Visn's Drug Patent Litigations
Johnson Johnson Visn's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 18, 2013, against patent number US9962376. The petitioner , challenged the validity of this patent, with Ranganath R. Raja et al as the respondent. Click below to track the latest information on how companies are challenging Johnson Johnson Visn's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US9962376 | November, 2013 |
Decision
(19 Apr, 2016)
| Ranganath R. Raja et al | |
Johnson Johnson Visn's Family Patents
Johnson Johnson Visn Drug List
Given below is the complete list of Johnson Johnson Visn's drugs and the patents protecting them.
1. Acuvue Theravision With Ketotifen
Acuvue Theravision With Ketotifen is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9962376 | Methods and ophthalmic devices used in the treatment of ocular allergies |
27 Jun, 2030
(5 years from now)
| Active |
| US9474746 | Methods for stabilizing oxidatively unstable compositions |
27 Mar, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acuvue Theravision With Ketotifen's drug page